feed
view company updates
tools
perform investment research
network
join events & discussions
advisory
about us
INVEST IN FUNDS
Lytix Biopharma: Directed Share Issue Sign of Strength
Research Note
2024-12-17
10:16
Redeye comments on the successful directed share issue of NOK100m and EUR1m primary bid offering.
Richard Ramanius
Sign up for free to continue
Sign up with Email
Sign in with Google
Already a member?
Sign in
Disclosures and disclaimers
Premium Plan required to unlock
Unlock companies to access
more high quality research.
View Plans